Zoeken

Uw resultaten

Resultaat 5 van 5 resultaten

Since its adoption, EU legislation on blood, tissues and cells has ensured an upward convergence in the quality and safety of these substances from donation to human application. Following an evaluation of the legislation, shortcomings have become apparent, primarily in light of scientific and technical developments in this area. Socio-demographic trends and new epidemiological risks have further consolidated the view that certain provisions of this legislation need to better reflect the current ...

The European Medicines Agency (EMA) is a decentralised agency of the EU. Its mission is to foster scientific excellence in the evaluation and supervision of medicines in the Member States of the EU and the European Economic Area. The EMA began operating in London in 1995. In the context of the United Kingdom's withdrawal from the EU (Brexit), the EMA will have to move to another location that will be decided upon by common agreement among the remaining 27 Member States (EU-27). The criteria and the ...

Each patient in the European Union has a right of access to care. National governments face the challenge to balance resources against healthcare demand to ensure that populations enjoy equitable access to effective, affordable and sustainable healthcare. This study describes the main challenges with regard to access to affordable medicines, including Research & Development, pricing and reimbursement of medicines and the influence of the economic crisis. Potential policy options to tackle these challenges ...

A Workshop organised by the Policy Department C was held on the impact of economic crisis on access to healthcare and medicines. The speakers addressed issues such as budget cuts in health care, high price of medicines, inequalities in access to various treatments as a direct result of those cuts, addressed medicines as a financial products with their share on stock market which creates an artificial incentive to keep the high value for medicines, etc. Better coordinated procurement for medicines ...

This document summarises the presentations and discussions of the workshop on access to medicines, held at the European Parliament in Brussels on Thursday 14 July 2016. The purpose of the workshop was to discuss the latest trends and the current situation as regards the availability of affordable medicines in Europe, to present a range of EU initiatives, and to raise awareness on prices, accessibility, acceptability, affordability and availability of medicines in the EU. During the first part of ...